jueves, 2 de enero de 2025

The era of GLP-1 receptor agonists: costs versus benefits The Lancet Diabetes & Endocrinology

https://www.thelancet.com/issue/S2213-8587(24)X0013-3

No hay comentarios:

Publicar un comentario